Items in AFP with MESH term: Cardiovascular Diseases
ABSTRACT: Thousands of young athletes receive preparticipation evaluations each year in the United States. One objective of these evaluations is to detect underlying cardiovascular abnormalities that may predispose an athlete to sudden death. The leading cardiovascular causes of sudden death in young athletes include hypertrophic cardiomyopathy, congenital coronary artery anomalies, repolarization abnormalities, and Marfan syndrome. Because these abnormalities are rare and difficult to detect clinically, it is recommended that family physicians use standardized history questions and examination techniques. Athletes, accompanied by their parents, if possible, should be asked about family history of cardiac disease and sudden death; personal cardiac history; and exercise-related symptoms, specifically syncope, chest pain, and palpitations. The physical examination should include blood pressure measurement, palpation of radial and femoral pulses, dynamic cardiac auscultation, and evaluation for Marfan syndrome. Athletes with "red flag" signs or symptoms may need activity restriction, special testing, and referral if the diagnosis is unclear.
Are Beta Blockers Effective First-line Treatments for Hypertension? - Cochrane for Clinicians
Aspirin for the Primary Prevention of Cardiovascular Events - U.S. Preventive Services Task Force
An Aspirin a Day Keeps the MI Away (For Some) - Editorials
Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions - U.S. Preventive Services Task Force
Do Vitamin C Supplements Reduce Cardiovascular Disease Mortality? - FPIN's Clinical Inquiries
Do ACE Inhibitors Decrease Mortality in Patients with Hypertension? - FPIN's Clinical Inquiries